Connect with us

Bloomberg Technology

Musk’s Drug Use Is Latest Headache for Tesla’s Board

Elon Musk’s reported drug use has Tesla board members facing a familiar quandary: having to decide what, if anything, to do about the chief executive subjecting directors and shareholders alike to great financial and legal risk. Bloomberg’s Max Chafkin joins Ed Ludlow and Caroline Hyde on “Bloomberg Technology.” ——– Like this video? Subscribe to Bloomberg…

Published

on

Elon Musk’s reported drug use has Tesla board members facing a familiar quandary: having to decide what, if anything, to do about the chief executive subjecting directors and shareholders alike to great financial and legal risk. Bloomberg’s Max Chafkin joins Ed Ludlow and Caroline Hyde on “Bloomberg Technology.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:

Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
Twitter:
Facebook:
Instagram:

Continue Reading
Advertisement
24 Comments

24 Comments

  1. @ithomas6897

    January 8, 2024 at 4:15 pm

    Haters sure do hate

  2. @brocktovar4523

    January 8, 2024 at 4:22 pm

    Imagine posting hit pieces like this and only having 125 views after 20 minutes while thinking your journalism is relevant.

  3. @AwesomeShamik

    January 8, 2024 at 4:23 pm

    “He smoked Marijuana on Joe rogan podcast… ” if hadn’t seen that particular podcast I would have brought the Elon junkie narrative that you guys are peddling.. Damn.. Disappointed… Won’t be following Bloomberg from now, thought you people had an incentive in promoting facts considering the tools that you sell. Guess I was wrong. Bye.

  4. @ElPatron42069

    January 8, 2024 at 4:24 pm

    It’s only ok if the hollyweird elites take “illegal drugs” but anyone else gets in trouble….what are they hiding?

  5. @sanshuma0

    January 8, 2024 at 4:29 pm

    Not as much headache for the board but for the #TSLA investors ))

  6. @josephgaal394

    January 8, 2024 at 4:30 pm

    Running out of BS…

  7. @duran9664

    January 8, 2024 at 4:30 pm

    F off 🤬😡
    Most of such “drugs” r totally legal in most the countries around the world 😡 only in collapsing America it’s illegal 😡

  8. @tauronval1404

    January 8, 2024 at 4:35 pm

    🤌🏻😂Come On! And this news without taking drugs?…

  9. @mathewmcfool

    January 8, 2024 at 4:36 pm

    lol they’re trying to take his companies from him. Elon ain’t going no where!

  10. @milescoleman910

    January 8, 2024 at 4:43 pm

    Completely made up story.
    Man has top secret clearance through NASA. Weed was not illegal when and where he smoked it 5 years ago. He Is not on any drugs. This is just stock suppression and bull for views.

  11. @brooklynknite

    January 8, 2024 at 4:45 pm

    I would too if i had to payback all that money.

  12. @makeguyver8596

    January 8, 2024 at 4:54 pm

    He’s not an alcoholic
    While most executives I’ve met certainly are
    He’s not a coke head
    While most millionaires tend to be
    He’s running multiple successful worldwide companies
    While you sit on your butt reporting about people who are successful

    So what’s the problem here
    The report or the reporting?

    • @skytech2501

      January 8, 2024 at 5:35 pm

      jealously is the problem.

    • @reedschmitt8196

      January 8, 2024 at 6:53 pm

      How do you know if any of this is true or false? That’s right, you don’t. So how about taking Elons balls out of your mouth.

  13. @Bryan-fb8dh

    January 8, 2024 at 4:56 pm

    Lol. 🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣Ahhhhhhhhhh. Good stuff!

  14. @Cuteacc

    January 8, 2024 at 5:11 pm

    Based lord

  15. @GranthamMann

    January 8, 2024 at 5:14 pm

    Obviously Elon has stepped on some toes and the WSJ, the shill propaganda outlet that it is, is doing it’s job to smear and tarnish his name.

  16. @derekwise

    January 8, 2024 at 6:17 pm

    Who’s this guy in the purple jacket in the blue shirt with the irresponsible reporting on the medication the FDA has reported as clinically evident to treat depression. This guy called it a club drug which it can be however when prescribed by a doctor is not a club drug it’s not a party drug it’s clinically proven through research to treat depression as well as post-traumatic stress disorder, panic disorder in various other clinical conditions. This is specifically why I watched no media I just stumbled upon this because I was interested in CES but your organization is trash and I subscribe to nothing, not Disney, no cable outlets, I don’t watch national or local news because it’s trash. Nothing in the media will change until journalists have a code of ethics, but your organizations are so corrupt that’ll never happen.

  17. @Argyles100

    January 8, 2024 at 6:38 pm

    The church lady’s of the left

  18. @fishforeverlife

    January 8, 2024 at 6:39 pm

    This is the beginning of them trying to discredit and take him down.

  19. @IbnBahtuta

    January 8, 2024 at 7:18 pm

    He’s America’s other stable genius.

  20. @user-sm6so2zh6c

    January 8, 2024 at 7:37 pm

    He needs to sell more Teslas for now !

  21. @PavelBendov

    January 8, 2024 at 8:07 pm

    It definitely works in his favor. Let it sink in.

  22. @trendingnews1033

    January 8, 2024 at 8:07 pm

    Big surprise there

Leave a Reply

Cancel reply

Your email address will not be published. Required fields are marked *

Bloomberg Technology

Can OpenAI’s Sam Altman Really Deliver?

A group of OpenAI employees quit and form Anthropic, a powerful rival. Their exit sparks concerns the company isn’t prioritizing AI safety. In this episode of Foundering, we examine hype around AI, both its utopic dreams and visions of doom. Listen now Like this video? Subscribe to Bloomberg Technology on YouTube: Watch the latest full…

Published

on

A group of OpenAI employees quit and form Anthropic, a powerful rival. Their exit sparks concerns the company isn’t prioritizing AI safety.

In this episode of Foundering, we examine hype around AI, both its utopic dreams and visions of doom. Listen now

Like this video? Subscribe to Bloomberg Technology on YouTube:

Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:

Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:

Listen to the daily Bloomberg Technology podcast here:

More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Bloomberg Technology

Elon Musk’s Pay Package and Broadcom’s Surge | Bloomberg Technology

Bloomberg’s Caroline Hyde and Tim Stenovec break down what to expect from Elon Musk’s $56 billion pay package vote as Tesla’s shareholder meeting kicks off. Plus, a look at Broadcom’s surge as AI demand boosts its results, and we break down the financial terms of Apple and OpenAI’s landmark agreement. 05:23 Apple & OpenAI’s Financial…

Published

on

Bloomberg’s Caroline Hyde and Tim Stenovec break down what to expect from Elon Musk’s $56 billion pay package vote as Tesla’s shareholder meeting kicks off. Plus, a look at Broadcom’s surge as AI demand boosts its results, and we break down the financial terms of Apple and OpenAI’s landmark agreement.

05:23 Apple & OpenAI’s Financial Terms
11:11 Millenia Capital Managing Partner Joe Zhao
24:38 Intuit CEO Sasan Goodarzi
33:53 Patron Partner Amber Atherton
——–
“Bloomberg Technology” is our daily news program focused exclusively on technology, innovation and the future of business hosted by Ed Ludlow from San Francisco and Caroline Hyde in New York.

Like this video? Subscribe and turn on the notifications for Bloomberg Technology on YouTube:

Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

Get the latest in tech from Silicon Valley and around the world here:

Follow Ed Ludlow on Twitter here:
Follow Caroline Hyde on Twitter here:

Connect with us on…
Twitter:
Facebook:
Instagram:

Continue Reading

Bloomberg Technology

What Broadcom’s AI-Fueled Rally Means for the Chip Sector

Broadcom, a chip supplier for Apple and other big tech companies, saw its shares rise sharply after delivering strong results and an upbeat forecast, lifted by robust demand for artificial intelligence products. Millennia Capital Managing Partner Joe Zhao joins Caroline Hyde and Tim Stenovec to discuss his outlook for the chip sector in the context…

Published

on

Broadcom, a chip supplier for Apple and other big tech companies, saw its shares rise sharply after delivering strong results and an upbeat forecast, lifted by robust demand for artificial intelligence products. Millennia Capital Managing Partner Joe Zhao joins Caroline Hyde and Tim Stenovec to discuss his outlook for the chip sector in the context of AI on “Bloomberg Technology.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:

 
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:
 
Listen to the daily Bloomberg Technology podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading

Trending